| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |